Clinical Trials Browser

Phase 1/2 × brigatinib × 1 year × Clear all

NCT04925609 2025-12-05

Briga-PED

Phase 1/2 Recruiting

LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic